Mandac B R, Hurvitz E A, Nelson V S
Department of Physical Medicine and Rehabilitation, University of Michigan Medical Center, Ann Arbor 48109.
Arch Phys Med Rehabil. 1993 Jan;74(1):96-7.
Rapid baclofen withdrawal is known to cause markedly increased spasticity, but high fever associated with this complication has not been reported. We describe a 13-year-old boy with sensory incomplete C1 quadriplegia two years after injury who was on 200mg of baclofen per day for spasticity. Concerns about adverse side effects prompted tapering of his baclofen. Severely increased spasticity was noted with associated hyperthermia to 107 degrees F after the dosage was gradually decreased. Sepsis work-up was negative, head computed tomography scan was unchanged, and electroencephalogram showed no epileptiform activity. Cooling blankets, intravenous diazepam, and return of baclofen to 160mg per day decreased spasticity and normalized body temperature without recurrence of hyperthermia. Possible fever etiology is the hypermetabolic state associated with the acute return of spasticity.
已知快速停用巴氯芬会导致痉挛明显加重,但尚未有关于该并发症伴发高热的报道。我们描述一名13岁男孩,受伤两年后出现感觉不完全性C1四肢瘫,因痉挛每日服用200毫克巴氯芬。对不良副作用的担忧促使逐渐减少其巴氯芬用量。在剂量逐渐减少后,发现痉挛严重加重,并伴有体温升高至107华氏度。脓毒症检查结果为阴性,头部计算机断层扫描无变化,脑电图显示无癫痫样活动。使用降温毯、静脉注射地西泮,并将巴氯芬用量恢复至每日160毫克后,痉挛减轻,体温恢复正常,未再出现高热。可能的发热病因是与痉挛急性复发相关的高代谢状态。